TCR-Alpha/Beta and CD19+ depleted KIR/KIR ligandmismatched Haploidentical Hematopoietic Stem Cell Transplant and Zolendronate for Pediatric Relapsed/ Refractory Hematologic Malignancies and High Risk Solid Tumor - Stand Up To Cancer

Blog

Posted October 11, 2019

TCR-Alpha/Beta and CD19+ depleted KIR/KIR ligandmismatched Haploidentical Hematopoietic Stem Cell Transplant and Zolendronate for Pediatric Relapsed/ Refractory Hematologic Malignancies and High Risk Solid Tumor

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.